Brain Tumour UK`s 9th Annual Patient and Carer Conference 7-8 July 2009
Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)
Posted on: 05/11/2009
Brain Tumour UK's 9th Annual Patient and Carer Conference 7-8 July 2009
Brain Tumour UK has announced the dates and venue for its highly
regarded annual conference for patients, carers and health
The flagship event is a special opportunity for people affected by
any type of brain tumour to share in new knowledge, make friends and
have their questions answered by experts.
This year, the conference is being held at the four-star Abbey Hotel
and Golf Club, within easy reach of Birmingham, Bristol and London.
Brain Tumour UK has negotiated very competitive rates, with the
result that the whole conference with full-board accommodation
costs just £120 per person. Bursaries are also available for patients
who are receiving benefits and for students.
As always, there is an impressive range of speakers. Professor David
MacDonald, Associate Professor of Neurology at the University of
Western Ontario, Canada, will provide an exciting perspective on
research in Canada and the United States. He’ll be complemented by
Dr Paul Mulholland from University College London Hospitals, who will
outline new research in the UK and Europe.
Dr Malcolm Galloway, Consultant Neuro-Pathologist at the Royal Free
Hospital in London will explain how we tell one tumour type from
another in order to deliver the right treatment.
Dr David Levy, Consultant Neuro-Oncologist from Weston Park Hospital
in Sheffield, will outline how the NHS is working to improve outcomes
for patients. And Maureen Dowling, Project Co-ordinator for the
Brain & CNS Survivorship Pathways Project will outline how the NHS is
working with Brain Tumour UK and others to develop a clear, clinical
‘pathway’ to ensure that patients are properly cared for in their
brain tumour journey, from the moment of diagnosis.
Professor Bleddyn Jones from the Institute for Particle Therapy
Cancer Research will present the exciting new technology that’s
emerging to treat brain tumours, and debate its future with Professor
Mike Brada from the Royal Marsden Hospital.
There will also be a host of experts from around the UK to lead
workshops and address delegate questions and concerns. Led by
Professor Garth Cruickshank, they’ll cover everything from treating
new and recurrent tumours through to caring for young people with
brain tumours and accessing benefits.
Click HERE to return to brain tumor news headlines